Today is World Atopic Eczema Day, established to enhance awareness, understanding and management of a skin condition that can severely affect patients’ health and wellbeing.
Momentum continues to build in the use of high-efficacy, disease modifying therapies (DMTs) as a first choice for treating multiple sclerosis. How is this being influenced by the availability of anti-CD20s, a new class of DMT? Will future new therapy classes change the paradigm even further?
The COVID-19 pandemic has been challenging for healthcare systems worldwide – with an already overburdened system and large population, the Indian healthcare system was no exception.
Ipsos partnered with the HLTH Foundation to shine a light on existing health tech-related inequities in the US and identify opportunities for the industry to address techquity gaps.